Verbatim response from ChatGPT
Short answer: most compounded “GLP‑1 drops or tablets” are not reliable and I do not recommend them. Use FDA‑approved products (oral semaglutide — Rybelsus — or one of the injectable GLP‑1/GIP drugs such as Ozempic, Wegovy, Mounjaro/Zepbound) or work with your clinician to find an approved, safe alternative.
Why compounded oral GLP‑1 products are risky and usually ineffective
- GLP‑1 drugs are peptides that are destroyed in the stomach/intestine and have very low oral bioavailability unless formulated specifically to be absorbed.
- Rybelsus (oral semaglutide) is the only widely approved oral GLP‑1; it uses a proprietary absorption enhancer (SNAC) and has been studied in clinical trials. Compounded drops/tablets generally lack validated formulation, absorption data, stability testing or dose‑equivalence to the approved drugs.
- Compounded products from unverified pharmacies can vary in potency, may be contaminated, and have no guarantee of sterility or consistent dosing. There are anecdotal reports of benefit, but no reliable randomized data proving safety or efficacy for these formulations.
- Injectables (Ozempic and Wegovy — semaglutide; Mounjaro/Zepbound — tirzepatide; Saxenda — liraglutide) have robust clinical-trial evidence showing greater and more consistent glucose control and weight loss than what you should expect from an untested compounded oral product.
What works and why
- Rybelsus (oral semaglutide): FDA‑approved oral GLP‑1 with clinical evidence for lowering A1c and modest weight loss. It must be taken on an empty stomach with a small sip of water and you must wait ~30 minutes before eating other meds/food for adequate absorption.
- Injectable GLP‑1/GIP drugs (Ozempic, Wegovy, Mounjaro/Zepbound, Saxenda): proven in multiple large trials to produce larger reductions in weight and blood glucose than oral semaglutide. They have predictable dosing and monitored safety data.
If cost or access is the issue
- Talk to your prescriber about Rybelsus first (if you want oral). If injections are recommended, ask about patient savings programs or coupons from manufacturers (e.g., Novo Nordisk for Wegovy/Ozempic, Eli Lilly for Mounjaro/Zepbound). GoodRx or your insurer’s specialty-pharmacy network can help with pricing.
- If a pharmacy suggests a “cheaper” compounded oral version, ask for written stability/bioavailability data and verify the compounding pharmacy is PCAB‑accredited — but even then the product won’t be FDA‑approved or proven.
Safety reminders
- GLP‑1s commonly cause nausea, vomiting, diarrhea; rare but serious risks include pancreatitis and possible thyroid C‑cell tumor signals seen in animals (contraindicated in patients with medullary thyroid carcinoma or MEN2). Always discuss medical history and medications with your clinician before starting any GLP‑1.
- If you’re offered a compounded product and experience an adverse event, seek medical care and report it to your provider and the appropriate regulatory agency.
Practical next steps
- Discuss with your primary care doctor or an endocrinologist which FDA‑approved option fits your goals (Rybelsus vs injectable agents).
- If cost is a blocker, ask about manufacturer assistance, specialty pharmacy options, or clinical trials.
- Avoid off‑label compounded oral versions unless you have a compelling, documented reason and you fully understand the unknowns and risks.
If you want, tell me whether your goal is diabetes control or weight loss, any medical issues/medications you’re on, and whether cost/access is a concern — I can suggest which approved product is most appropriate and point you to assistance programs.